Cardiac prostheses‐related hemolytic anemia

Hemolysis is an unintended sequel of temporary or permanent intracardiac devices. However, limited data exist on the characteristics and treatment of hemolysis in patients with cardiac prostheses. This entity, albeit uncommon, often poses significant diagnostic and management challenges to the clini...

Full description

Saved in:
Bibliographic Details
Published inClinical cardiology (Mahwah, N.J.) Vol. 42; no. 7; pp. 692 - 700
Main Authors Alkhouli, Mohamad, Farooq, Ali, Go, Ronald S., Balla, Sudarshan, Berzingi, Chalak
Format Journal Article
LanguageEnglish
Published New York Wiley Periodicals, Inc 01.07.2019
John Wiley & Sons, Inc
Subjects
Anemia
Anemia, Hemolytic - epidemiology
Anemia, Hemolytic - etiology
cardiac prosthesis
Cardiology
Global Health
Heart
Heart Valve Prosthesis - adverse effects
Heart Valve Prosthesis Implantation - adverse effects
hemolysis
Humans
Incidence
left ventricular assist device
paravalvular leak
Prostheses
Review
paravalvular leak
cardiac prosthesis
left ventricular assist device
anemia
hemolysis
Online AccessGet full text

Cover

More Information
Summary:Hemolysis is an unintended sequel of temporary or permanent intracardiac devices. However, limited data exist on the characteristics and treatment of hemolysis in patients with cardiac prostheses. This entity, albeit uncommon, often poses significant diagnostic and management challenges to the clinical cardiologist. In this article, we aim to provide a contemporary overview of the incidence, mechanisms, diagnosis, and management of cardiac prosthesis‐related hemolysis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0160-9289
1932-8737
DOI:10.1002/clc.23191